JY
AVNS

Jeff Yass’s Avanos Medical AVNS Stock Holding History

Jeff Yass’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+60,300
New +$1.41M ﹤0.01% 7166
2020
Q3 		– Sell
-9,400
Closed -$276K – 10523
2020
Q2 		$276K Sell
9,400
-13,700
-59% -$397K ﹤0.01% 8495
2020
Q1 		$622K Buy
23,100
+12,900
+126% +$385K ﹤0.01% 6452
2019
Q4 		$344K Buy
+10,200
New +$369K ﹤0.01% 7749
2019
Q2 		– Sell
-11,000
Closed -$469K – 10191
2019
Q1 		$469K Buy
+11,000
New +$493K ﹤0.01% 6406
2018
Q4 		– Sell
-49,300
Closed -$3.38M – 8902
2018
Q3 		$3.38M Buy
49,300
+1,200
+2% +$77.2K ﹤0.01% 3194
2018
Q2 		$2.75M Sell
48,100
-3,900
-8% -$206K ﹤0.01% 3507
2018
Q1 		$2.4M Buy
52,000
+10,400
+25% +$494K ﹤0.01% 3592
2017
Q4 		$1.92M Buy
41,600
+3,700
+10% +$170K ﹤0.01% 3975
2017
Q3 		$1.71M Sell
37,900
-28,700
-43% -$1.22M ﹤0.01% 4198
2017
Q2 		$2.62M Buy
66,600
+22,700
+52% +$858K ﹤0.01% 3395
2017
Q1 		$1.67M Buy
43,900
+11,000
+33% +$429K ﹤0.01% 4054
2016
Q4 		$1.22M Sell
32,900
-10,500
-24% -$375K ﹤0.01% 5102
2016
Q3 		$1.5M Sell
43,400
-31,500
-42% -$1.1M ﹤0.01% 4042
2016
Q2 		$2.44M Buy
74,900
+43,700
+140% +$1.34M ﹤0.01% 3248
2016
Q1 		$896K Sell
31,200
-24,500
-44% -$653K ﹤0.01% 5299
2015
Q4 		$1.86M Sell
55,700
-24,600
-31% -$765K ﹤0.01% 4178
2015
Q3 		$2.28M Sell
80,300
-23,900
-23% -$834K ﹤0.01% 4018
2015
Q2 		$4.22M Buy
104,200
+26,800
+35% +$1.2M ﹤0.01% 3194
2015
Q1 		$3.81M Buy
77,400
+44,400
+135% +$2.06M ﹤0.01% 3145
2014
Q4 		$1.5M Buy
+33,000
New +$1.3M ﹤0.01% 5038

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jeff Yass's AVNS Position: Q2 2026 in Review

Jeff Yass reduced its Avanos Medical (AVNS) stake by 37% in Q2 2026, selling an estimated $161K and leaving 11,645 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #11123.

Jeff Yass first reported a position in AVNS in Q4 2014 and has held it in 31 quarters since. The position peaked at $6.59M in Q1 2015. 284 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Jeff Yass held 11,645 shares of Avanos Medical worth $290K as of Q2 2026.
  • Jeff Yass sold 6,867 Avanos Medical shares in Q2 2026, an estimated $161K.
  • Avanos Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11123 holding.
  • Jeff Yass first reported a position in Avanos Medical in Q4 2014 and has held it in 31 quarters since.
  • Jeff Yass's Avanos Medical position peaked at $6.59M in Q1 2015.
  • 284 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.